U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06899360) titled 'Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macular Degeneration.' on March 12.
Brief Summary: The VERA-AMD study is a prospective, observational study designed to evaluate clinical progression, prognostic factors, and quality of life in patients with age-related macular degeneration (AMD). The study aims to analyze real-world clinical data to identify key predictors of disease progression and functional outcomes, with the goal of optimizing AMD management. The study involves 200 patients aged >=50 with a confirmed diagnosis of AMD, monitored through routine clinical prac...